P3 Study Brodalumab in Treatment of Moderate to Severe Plaque Psoriasis
Clinical trial NCT01708603 · TERMINATED
Trial details
- NCT number
- NCT01708603
- Sponsor
- Bausch Health Americas, Inc.
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2012-08-01
- Primary completion
- 2014-09-01
- Enrollment
- 1831
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.